Inventor
BOLLAG WERNER
CH30 patents
⚠️ This page may combine multiple inventors who share the name “BOLLAG WERNER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
28 patentsUS4215215AJul 29, 1980
9-Phenyl-nonate traene compounds
HOFFMANN LA ROCHE38 citations92
US4105681AAug 8, 1978
9-phenyl 5,6-dimethyl-nona-2,4,6,8-tetraeonic acid compounds
HOFFMANN LA ROCHE48 citations92
US6326397B1Dec 4, 2001
Retinoid antagonists and use thereof
HOFFMANN LA ROCHE24 citations91
US6133309AOct 17, 2000
Treatment of T-helper cell type 2-mediated immune disease by retinoid antagonists
HOFFMANN LA ROCHE40 citations91
US5428071AJun 27, 1995
Prevention and treatment of premalignant epithelial lesions and malignant tumors of epithelial origin
HOFFMANN LA ROCHE28 citations86
US4054589AOct 18, 1977
Novel 9-substituted phenyl-3,7-dimethyl-nona-2,4,6,8-tetraene esters
HOFFMANN LA ROCHE29 citations81
US4021574AMay 3, 1977
Antidandruff compositions containing 9-(4-lower alkoxy-2,3,6-trilower-alkylphenyl)-3,7-dimethyl-nona-2,4,6,8-tetraen-1-oic acid lower alkyl amides
HOFFMANN LA ROCHE18 citations81
US3984440AOct 5, 1976
Polyene compounds
HOFFMANN LA ROCHE28 citations81
US3950418AApr 13, 1976
Vitamin A acid amides
HOFFMANN LA ROCHE31 citations81
US4464394AAug 7, 1984
Compositions and methods for using 13-cis vitamin A acid compounds
HOFFMANN LA ROCHE18 citations74
US4656310AApr 7, 1987
Substituted triarylphosphonium derivatives
HOFFMANN LA ROCHE10 citations73
US4316983AFeb 23, 1982
Neoplasmic compounds: sugar esters and glycosides
HOFFMANN LA ROCHE9 citations73
US4224244ASep 23, 1980
9-Phenyl 5,6-dimethyl-nona-2,4,6,8 tetraenal or tetraenol derivatives
HOFFMANN LA ROCHE9 citations73
US6610742B1Aug 26, 2003
Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
HOFFMANN LA ROCHE8 citations72
US4565863AJan 21, 1986
Retinoid carbohydrates
HOFFMANN LA ROCHE17 citations72
US4225527ASep 30, 1980
Polyene compounds
HOFFMANN LA ROCHE9 citations71
US4200647AApr 29, 1980
Vitamin A compositions to treat rheumatic disease
HOFFMANN LA ROCHE12 citations66
US4863969ASep 5, 1989
Treatment of premalignant lesions and certain malignant tumors
HOFFMANN LA ROCHE5 citations63
US4719238AJan 12, 1988
Treatment of diseases which cause pathological cornification of the epidermis of the skin
HOFFMANN LA ROCHE2 citations63
US4532355AJul 30, 1985
Substituted triaryl phosphonium derivatives
HOFFMANN LA ROCHE2 citations62
US4319048AMar 9, 1982
Certain 6-(3'-methoxyphenyl) derivatives of 2,4-hexadienal
HOFFMANN LA ROCHE1 citations62
US4163103AJul 31, 1979
Novel derivatives of 9-substituted phenyl-3,7-dimethyl-nona-2,4,6,8-tetraene
HOFFMANN LA ROCHE3 citations62
US3931268AJan 6, 1976
Methylhydrazinomethyl-substituted benzoic acid amides
HOFFMANN LA ROCHE3 citations54
US4689350AAug 25, 1987
Treatment of dermatoses and illnesses producing inflammation
HOFFMANN LA ROCHE1 citations52
US4187247AFeb 5, 1980
9-Substituted phenyl-3,7-dimethyl-nona 2,4,6,8-tetraene compounds
HOFFMANN LA ROCHE1 citations51
US4107190AAug 15, 1978
Novel compounds of 9-phenyl-3,7-dimethyl-2,4,6,8-nonatetraenamide
HOFFMANN LA ROCHE1 citations51
US4044051AAug 23, 1977
9[2-(1-Alkoxy-ethyl)-5,5-dimethyl-cyclopent-1-en-1-yl]-3,7-dimethyl-nona-2,4,6,8-tetraen acid compounds
HOFFMANN LA ROCHE1 citations51
US4267382AMay 12, 1981
2,6-Dichloro-4-methoxy-5-methyl-benzene aldehydes
HOFFMANN LA ROCHE0 citations50